Home › Funds › Prudential Financial › GILD

Prudential Financial position in GILD

GILEAD SCIENCES INC · Health Care

Prudential Financial reported holding 2,044,749 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$304.8M, representing 0.33% of its reported portfolio and ranking #49 among its reported holdings. Prudential Financial has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)2.04M sh
Reported value held$304.77M
Portfolio Weight0.33%
First reportedQ3 2021
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Prudential Financial's GILD position evolved

Prudential Financial first disclosed a stake in GILD in Q3 2021 at 1,951,163 shares (US$138.9M). The position peaked in Q3 2026 at 2,044,749 shares, worth US$304.8M. Across 21 filings, Prudential Financial increased the stake 10 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,044,749 shares valued at US$304.8M — an increase of 285,400 shares quarter over quarter.. Notable position changes include a 40% increase in Q2 2025 (shares were roughly flat over the following quarter), a 38% increase in Q3 2025 (shares rose 10% over the following quarter), a 38% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 1.95M $138.88M New
Q4 2021 1.66M $112.64M Reduce
Q1 2022 2.17M $129.09M Add
Q2 2022 2.69M $166.47M Add
Q3 2022 2.71M $167.50M Add
Q4 2022 2.13M $182.86M Reduce
Q1 2023 2.11M $175.45M Reduce
Q2 2023 2.05M $157.69M Reduce
Q3 2023 1.28M $95.80M Reduce
Q4 2023 1.40M $112.52M Add
Q1 2024 914.87K $67.01M Reduce
Q2 2024 854.25K $58.61M Reduce
Q3 2024 1.03M $82.19M Add
Q4 2024 981.25K $90.64M Reduce
Q1 2025 1.22M $136.85M Add
Q2 2025 1.71M $189.34M Add
Q3 2025 2.35M $261.13M Add
Q4 2025 2.03M $249.23M Reduce
Q1 2026 1.28M $177.71M Reduce
Q2 2026 1.76M $222.28M Add
Q3 2026 2.04M $304.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Prudential Financial held GILD?

Prudential Financial has disclosed GILD holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Prudential Financial's current position in GILD?

As of Q3 2026, Prudential Financial holds 2.04M shares of GILD (GILEAD SCIENCES INC), valued at $304.77M, representing 0.33% of its reported portfolio and ranking #49.

Has Prudential Financial been buying or selling GILD?

In the latest 13F filing (Q3 2026), Prudential Financial increased its position in GILD. The position peaked in Q3 2026 at 2.04M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.